Evidence map›Paper›PMID 32585002›Full record

ArticleNucleic acids research2020

Activation of transcription factor circuity in 2i-induced ground state pluripotency is independent of repressive global epigenetic landscapes.

Ruchi Shukla, Heidi K Mjoseng, John P Thomson, Simon Kling, Duncan Sproul, Donncha S Dunican, Bernard Ramsahoye, Tuempong Wongtawan, Fridolin Treindl, Markus F Templin and 3 more

Open access · goldAbstract read
In one paragraph

Article in Nucleic acids research, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.4field-weighted citation impact, top 40% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 4 institutions in 2 countries.

Ruchi ShuklaMRC Human Genetics Unit, Institute of Genetics and Molecular Medicine, WGH, University of Edinburgh, Edinburgh EH4 2XU, UK.
Heidi K MjosengMRC Human Genetics Unit, Institute of Genetics and Molecular Medicine, WGH, University of Edinburgh, Edinburgh EH4 2XU, UK.
John P ThomsonMRC Human Genetics Unit, Institute of Genetics and Molecular Medicine, WGH, University of Edinburgh, Edinburgh EH4 2XU, UK.
Simon KlingNMI Natural and Medical Sciences Institute, Tübingen University, Reutlingen, Germany.
Duncan SproulMRC Human Genetics Unit, Institute of Genetics and Molecular Medicine, WGH, University of Edinburgh, Edinburgh EH4 2XU, UK.
Donncha S DunicanMRC Human Genetics Unit, Institute of Genetics and Molecular Medicine, WGH, University of Edinburgh, Edinburgh EH4 2XU, UK.
Bernard RamsahoyeCentre for Genomic and Experimental Medicine, Institute of Genetics and Molecular Medicine, WGH, University of Edinburgh, Edinburgh EH4 2XU, UK.
Tuempong WongtawanCentre for Cardiovascular Science, Queen's Medical Research Institute, University of Edinburgh, Edinburgh EH16 4TJ, UK.
Fridolin TreindlNMI Natural and Medical Sciences Institute, Tübingen University, Reutlingen, Germany.
Markus F TemplinNMI Natural and Medical Sciences Institute, Tübingen University, Reutlingen, Germany.
Ian R AdamsMRC Human Genetics Unit, Institute of Genetics and Molecular Medicine, WGH, University of Edinburgh, Edinburgh EH4 2XU, UK.
Sari PenningsCentre for Cardiovascular Science, Queen's Medical Research Institute, University of Edinburgh, Edinburgh EH16 4TJ, UK.
Richard R MeehanMRC Human Genetics Unit, Institute of Genetics and Molecular Medicine, WGH, University of Edinburgh, Edinburgh EH4 2XU, UK.
Institute of Genetics and Cancer · GBNatural and Medical Sciences Institute · DEThe Queen's Medical Research Institute · GBUniversity of Edinburgh · GB

Funding

Cancer Research UK 20837Medical Research Council MC PC U127574433Medical Research Council MC_PC_U127574433Medical Research Council MC_UU_00007/17Medical Research Council MC UU 00007/6Medical Research Council MC_UU_00007/6Medical Research Council MC UU 0007/17
6 · The paper itself

Abstract

Mouse embryonic stem cells (mESCs) cultured with MEK/ERK and GSK3β (2i) inhibitors transition to ground state pluripotency. Gene expression changes, redistribution of histone H3K27me3 profiles and global DNA hypomethylation are hallmarks of 2i exposure, but it is unclear whether epigenetic alterations are required to achieve and maintain ground state or occur as an outcome of 2i signal induced changes. Here we show that ESCs with three epitypes, WT, constitutively methylated, or hypomethylated, all undergo comparable morphological, protein expression and transcriptome changes independently of global alterations of DNA methylation levels or changes in H3K27me3 profiles. Dazl and Fkbp6 expression are induced by 2i in all three epitypes, despite exhibiting hypermethylated promoters in constitutively methylated ESCs. We identify a number of activated gene promoters that undergo 2i dependent loss of H3K27me3 in all three epitypes, however genetic and pharmaceutical inhibition experiments show that H3K27me3 is not required for their silencing in non-2i conditions. By separating and defining their contributions, our data suggest that repressive epigenetic systems play minor roles in mESC self-renewal and naïve ground state establishment by core sets of dominant pluripotency associated transcription factor networks, which operate independently from these epigenetic processes.

Indexed as

Epigenetic RepressionGene Regulatory NetworksAnimalsCells, CulturedDNA MethylationEpigenesis, GeneticGlycogen Synthase Kinase 3 betaHistonesMaleMiceMitogen-Activated Protein Kinase KinasesMouse Embryonic Stem CellsTranscription FactorsTranscription, GeneticGlycogen Synthase Kinase 3 betaGsk3b protein, mouseHistonesMitogen-Activated Protein Kinase KinasesTranscription Factors

Identifiers

PMID32585002
PMCPMC7641322
OpenAlexW3038001552

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.